Of note, although the analysis of human serum levels only exhibited a numerical trend toward decreased NF-L serum concentrations in stroke patients who underwent recanalizing therapies, the resulting values after acute therapy are comparable with TIA patients and therefore comply with studies suggesting serum NF-L measurements as a useful tool to monitor treatment responses in neurological diseases [78, 79]. Here, NEFL is linked to nervous system disorder.